Chemo after colon cancer surgery for adults 70 and older
Part of Cancer, Digestive system clinical trials.
This Phase 3 trial studies whether giving chemotherapy after surgery helps people age 70+ with stage III colon cancer. You would be compared to another planned treatment approach, aiming to lower the chance of the cancer coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 70 years old or older
- You had stage III colon cancer removed with clean margins (R0 resection)
- Your surgery was followed by starting the study chemotherapy within 12 weeks
- You have not had chemotherapy for colon cancer before
- Your blood counts and overall condition are high enough for chemotherapy (specific lab thresholds apply)
- You complete study paperwork and can attend follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving 6 weeks of chemotherapy (FOLFOX) before surgery can help people aged 70 and older with locally advanced colon cancer. It aims to make treatment safer and more effective for older adults.
This trial tests two chemotherapy drugs, capecitabine alone or with oxaliplatin, in people aged 70 or older after surgery for stage III colorectal cancer. The goal is to find out which treatment works better to prevent cancer from coming back.
This trial tests giving mFOLFIRINOX chemotherapy after curative surgery for people with high-risk stage III colon cancer. It aims to lower the chance that cancer comes back.
This trial tests whether using a ctDNA blood test can help choose the best chemotherapy after colon cancer surgery for people aged 70–80. It aims to make treatment more personalized and reduce side effects.
This trial tests whether giving chemotherapy before surgery can improve outcomes for people with colon cancer that has grown into nearby tissue or lymph nodes but hasn't spread to other organs. It is for patients whose tumors are mismatch repair proficient (pMMR) or microsatellite stable (MSS).
This trial studies whether adding chemotherapy after surgery helps people with colon cancer that was diagnosed before surgery as stage III and later found to be without certain high-risk features. It may help lower the chance the cancer comes back, but you must meet specific surgery and health criteria.
Hear when a new Colonic Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.